Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Amdocs stock (DOX)

Buy Amdocs stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Amdocs is a software - infrastructure business based in the US. Amdocs shares (DOX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $85.61 – a decrease of 3.2% over the previous week.

Our top picks for where to buy Amdocs stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy Amdocs stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – DOX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Amdocs stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Amdocs stock price (NASDAQ: DOX)

Use our graph to track the performance of DOX stocks over time.

Amdocs shares at a glance

Information last updated 2024-12-11.
Latest market close$85.61
52-week range$73.55 - $93.34
50-day moving average $88.08
200-day moving average $85.39
Wall St. target price$100.33
PE ratio 20.5012
Dividend yield $1.872 (2.23%)
Earnings per share (TTM) $4.25

Is it a good time to buy Amdocs stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amdocs price performance over time

Historical closes compared with the close of $86.92 from 2024-12-17

1 week (2024-12-11) -0.24%
1 month (2024-11-19) 4.80%
3 months (2024-09-19) -0.42%
6 months (2024-06-18) 13.84%
1 year (2023-12-18) -0.24%
2 years (2022-12-16) 3.48%
3 years (2021-12-17) 26.82%
5 years (2019-12-18) 33.58%

Is Amdocs stock undervalued or overvalued?

Valuing Amdocs stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amdocs's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amdocs's P/E ratio

Amdocs's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, Amdocs shares trade at around 21x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Amdocs's PEG ratio

Amdocs's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1258. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amdocs's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Amdocs's EBITDA

Amdocs's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $949.8 million.

The EBITDA is a measure of a Amdocs's overall financial performance and is widely used to measure a its profitability.

Amdocs financials

Revenue TTM $5 billion
Operating margin TTM 15.5%
Gross profit TTM $1.6 billion
Return on assets TTM 7.38%
Return on equity TTM 14.05%
Profit margin 9.85%
Book value $30.39
Market Capitalization $10 billion

TTM: trailing 12 months

Amdocs share dividends

30%

Dividend payout ratio: 29.75% of net profits

Recently Amdocs has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Amdocs shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Amdocs's case, that would currently equate to about $1.872 per share.

While Amdocs's payout ratio might seem fairly standard, it's worth remembering that Amdocs may be investing much of the rest of its net profits in future growth.

Amdocs's most recent dividend payout was on 30 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 30 December 2024 (the "ex-dividend date").

Amdocs share price volatility

Over the last 12 months, Amdocs's shares have ranged in value from as little as $73.5518 up to $93.34. A popular way to gauge a stock's volatility is its "beta".

DOX.US volatility(beta: 0.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amdocs's is 0.747. This would suggest that Amdocs's shares are less volatile than average (for this exchange).

Amdocs overview

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers. It also offers AI-powered, cloud-native, and home operating systems; data intelligence solutions and applications; end-to-end application development and maintenance services; and ongoing maintenance services. In addition, the company provides a line of services designed for various stages of a service provider's lifecycle includes consulting, delivery, quality engineering, operations, systems integration, network services, experience-driven services, data, cloud, and content services; managed services comprising application development, modernization and maintenance, IT and infrastructure services, testing and professional services that are designed to assist customers in the selection, implementation, operation, management, and maintenance of IT systems. It serves to the communications, entertainment, and media industry service providers, as well as mobile virtual network operators. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri.

Frequently asked questions

null
What percentage of Amdocs is owned by institutions?
Currently 98.399% of Amdocs shares are held by institutions.
When does the fiscal year end for Amdocs?
Amdocs's fiscal year ends in September.
Where is Amdocs based?
Amdocs's address is: 625 Maryville Centre Drive, Saint Louis, MO, United States, 63141
What is Amdocs's ISIN number?
Amdocs's international securities identification number is: USG026021034
What is Amdocs's CUSIP number?
Amdocs's Committee on Uniform Securities Identification Procedures number is: G02602103

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site